CurrentRheuma
Get Weekly

Topic · page 8 of 17

Systemic sclerosis & Raynaud's

Limited and diffuse systemic sclerosis, skin, lung (interstitial lung disease), pulmonary arterial hypertension, heart, gut and kidney involvement in systemic sclerosis, digital ulcers, primary and secondary Raynaud's phenomenon, very early systemic sclerosis

Briefs 281–320 of 671 placed here, newest publication first

Briefs in Systemic sclerosis & Raynaud's

Newest publication first

  1. Rheumatology (Oxford)

    CAPI-Detect: machine learning in capillaroscopy reveals new variables influencing diagnosis

    Diagnostic or prognostic study

  2. Rheumatology (Oxford)

    A phase 2 randomized trial of safety and pharmacokinetics of IgPro20 and IgPro10 in patients with diffuse cutaneous systemic sclerosis

    Randomized controlled trial

  3. Rheumatology (Oxford)

    The role of prokinetics in managing gastrointestinal involvement in SSc: a systematic literature review

    Research article

  4. Arthritis Care Res (Hoboken)

    Immunosuppressive Drugs in Early Systemic Sclerosis and Prevention of Damage Accrual

    Cohort study

  5. Ann Rheum Dis

    Dysfunctional KLRB1+CD8+ T-cell responses are generated in chronically inflamed systemic sclerosis skin

    Mechanistic study

  6. Ann Rheum Dis

    Post hoc comparison of the effectiveness of tocilizumab, rituximab, mycophenolate mofetil, and cyclophosphamide in patients with SSc-ILD from the EUSTAR database

    Cohort study

  7. Lancet Rheumatol

    Faecal microbiota transplantation in patients with systemic sclerosis and lower gastrointestinal tract symptoms in Norway (ReSScue): a phase 2, randomised, double-blind, placebo-controlled trial

    Randomized controlled trial

  8. Semin Arthritis Rheum

    Semi-quantitatively scored apical extent of disease predicts change in total lung capacity in patients with systemic sclerosis and early interstitial lung disease.

    Cohort study

  9. Semin Arthritis Rheum

    Management of disease progression after autologous hematopoietic stem cell transplantation in systemic sclerosis: Results from an international questionnaire-based study

    Cross-sectional study

  10. Rheumatology (Oxford)

    A comparative analysis of risk stratification tools in SSc-associated pulmonary arterial hypertension: a EUSTAR analysis

    Cohort study

  11. Rheumatology (Oxford)

    Foot peripheral sensory neuropathy: a frequent disabling manifestation in systemic sclerosis

    Cross-sectional study

  12. Rheumatology (Oxford)

    Cross-trait GWAS in COVID-19 and systemic sclerosis reveals novel genes implicated in fibrotic and inflammation pathways

    Meta-analysis

  13. Rheumatology (Oxford)

    Prediction of scleroderma renal crisis in patients of SSc: insight from the CRDC cohort study

    Cohort study

  14. J Rheumatol

    Pulmonary Arterial Hypertension Incidence in Patients With Systemic Sclerosis Treated With Bosentan for Digital Ulcers: Evidence From the SPRING-SIR Registry

    Cohort study

  15. J Rheumatol

    Psychometric Evaluation of the Scleroderma Skin Questionnaire: A Novel Patient-Reported Outcome for Skin Disease in Patients With Systemic Sclerosis

    Diagnostic or prognostic study

  16. Arthritis Care Res (Hoboken)

    Treatment Response Biomarkers for Systemic Sclerosis–Associated Interstitial Lung Disease

    Secondary analysis

  17. Arthritis Rheumatol

    Autologous Nonmyeloablative Hematopoietic Stem Cell Transplantation for Diffuse Cutaneous Systemic Sclerosis: Identifying Disease Risk Factors for Toxicity and Long‐Term Outcomes in a Prospective, Single‐Arm Trial

    Cohort study

  18. Arthritis Care Res (Hoboken)

    Oral Glucocorticoids for Skin Fibrosis in Early Diffuse Systemic Sclerosis: A Target Trial Emulation Study From the European Scleroderma Trials and Research Group Database

    Cohort study

  19. Semin Arthritis Rheum

    Immunosuppressive therapy to treat newly diagnosed primary heart involvement in patients with systemic sclerosis: An Italian cardiac magnetic resonance based study

    Cohort study

  20. Rheumatology (Oxford)

    Gastroesophageal reflux disease is associated with a more severe interstitial lung disease in systemic sclerosis in the EUSTAR cohort

    Cohort study

  21. Arthritis Rheumatol

    Characterization of Incident Interstitial Lung Disease in Late Systemic Sclerosis

    Cohort study

  22. Rheumatology (Oxford)

    Tocilizumab and rituximab for systemic sclerosis interstitial lung disease: a real-world cohort analysis

    Cohort study

  23. Ann Rheum Dis

    EULAR recommendations for the treatment of systemic sclerosis: 2023 update

    Guideline or statement

  24. Ann Rheum Dis

    Human hypofunctional NCF1 variants promote pulmonary fibrosis in the bleomycin-induced mouse model and patients with systemic sclerosis via expansion of SPP1+ monocytes-derived macrophages

    Case-control study

  25. Ann Rheum Dis

    Results from the international collaborative systematic literature review informing the 2023 EULAR recommendations for the treatment of systemic sclerosis

    Research article

  26. Rheumatology (Oxford)

    Predictors of rituximab efficacy in systemic sclerosis-associated interstitial lung disease: machine-learning analysis of the DESIRES trial

    Secondary analysis

  27. Rheumatology (Oxford)

    Biological hallmarks of systemic sclerosis are present in the skin and serum of patients with Very Early Diagnosis of Systemic Sclerosis (VEDOSS)

    Mechanistic study

  28. Arthritis Res Ther

    Quantitative 18F-FDG PET-CT can assess presence and extent of interstitial lung disease in early severe diffuse cutaneous systemic sclerosis

    Cross-sectional study

  29. Rheumatology (Oxford)

    Systemic sclerosis–related fecal incontinence: a scoping review focusing on a neglected manifestation

    Research article

  30. Rheumatology (Oxford)

    Elevated Fcy receptor expression augments pro-inflammatory macrophage phagocytosis in systemic sclerosis and associated rheumatic diseases

    Mechanistic study

  31. Arthritis Rheumatol

    A Strong Dysregulated Myeloid Component in the Epigenetic Landscape of Systemic Sclerosis: An Integrated DNA Methylome and Transcriptome Analysis

    Research article

  32. RMD Open

    Vasodilator drugs and heart-related outcomes in systemic sclerosis: an exploratory analysis

    Cohort study

  33. Rheumatology (Oxford)

    Longitudinal trajectories of the Scleroderma Health Assessment Questionnaire (SHAQ) visual analogue scales: a retrospective cohort study

    Cohort study

  34. Semin Arthritis Rheum

    Accrual of organ damage and one-year mortality in systemic sclerosis: A prospective observational study

    Cohort study

  35. Rheumatology (Oxford)

    Dermal cellular senescence and EndMT in patients with systemic sclerosis undergoing cyclophosphamide or aHSCT treatment

    Secondary analysis

  36. Semin Arthritis Rheum

    Phenotype of diffuse cutaneous systemic sclerosis patients with positive anticentromere antibodies: A systematic literature review and meta-analysis

    Meta-analysis

  37. J Rheumatol

    Association of the Apollo Wearable With Fatigue, Raynaud Phenomenon, and Quality of Life in Patients With Systemic Sclerosis: A Pilot Study

    Research article

  38. RMD Open

    Performance of the EULAR Systemic sclerosis Impact of Disease (ScleroID) questionnaire as a patient-reported outcome measure for patients with diffuse systemic sclerosis

    Diagnostic or prognostic study

  39. Rheumatology (Oxford)

    Pulmonary involvement in systemic sclerosis: can sex play a role?

    Cohort study

  40. Semin Arthritis Rheum

    Quantification of coronary artery calcification in systemic sclerosis using visual ordinal and deep learning scoring: Association with systemic sclerosis clinical features

    Cohort study

All 671 Briefs in ExploreShowing Briefs 281–320 of 671, newest first